R. L. Mehta, M. T. Pascual, S. Soroko, B. R. Savage, J. Himmelfarb et al., Spectrum of acute renal failure in the intensive care unit: the PICARD experience, Kidney Int, vol.66, issue.4, pp.1613-1634, 2004.

T. Ali, I. Khan, W. Simpson, G. Prescott, J. Townend et al., Incidence and Outcomes in Acute Kidney Injury: A Comprehensive Population-Based Study, J Am Soc Nephrol. 4 janv, vol.18, issue.4, pp.1292-1300, 2007.

S. Uchino, J. A. Kellum, R. Bellomo, G. S. Doig, H. Morimatsu et al., Acute Renal Failure in Critically Ill Patients: A Multinational, Multicenter Study, JAMA. 17 août, vol.294, issue.7, pp.813-821, 2005.

S. G. Coca, S. Singanamala, and C. R. Parikh, Chronic kidney disease after acute kidney injury: a systematic review and meta-analysis, Kidney Int. mars, vol.81, issue.5, pp.442-450, 2012.

J. Jones, J. Holmen, D. Graauw, J. Jovanovich, A. Thornton et al., Association of complete recovery from acute kidney injury with incident CKD stage 3 and all-cause mortality, Am J Kidney Dis Off J Natl Kidney Found. sept, vol.60, issue.3, pp.402-410, 2012.

J. L. Xue, F. Daniels, R. A. Star, P. L. Kimmel, P. W. Eggers et al., Incidence and Mortality of Acute Renal Failure in Medicare Beneficiaries, J Am Soc Nephrol, vol.17, issue.4, pp.1135-1177, 1992.

G. M. Chertow, E. Burdick, M. Honour, J. V. Bonventre, and D. W. Bates, Acute Kidney Injury, Mortality, Length of Stay, and Costs in Hospitalized Patients, J Am Soc Nephrol. 11 janv, vol.16, issue.11, pp.3365-70, 2005.

K. Acute and . Kdigo, , 2016.

. Disponible,

B. Ponte, P. Saudan, and . L'insuffisance, , 2008.

. Revue-médicale-suisse, , 2017.

J. A. Kellum and N. Lameire, Diagnosis, evaluation, and management of acute kidney injury: a KDIGO summary (Part 1), Crit Care, vol.17, issue.1, p.204, 2013.

M. A. Perazella, Renal Vulnerability to Drug Toxicity, Clin J Am Soc Nephrol. 7 janv, vol.4, issue.7, pp.1275-83, 2009.

S. Zimner-rapuch, S. Amet, J. N. Deray, G. Launay-vacher, and V. , , 2013.

. Disponible,

M. Bentley and B. Mcdaniel, The role of medications and their management in acute kidney injury, 2015.

. Disponible,

L. Prieto-garcía, M. Pericacho, S. M. Sancho-martínez, Á. Sánchez, C. Martínez-salgado et al., Mechanisms of triple whammy acute kidney injury, Pharmacol Ther. nov, vol.167, pp.132-177, 2016.

J. Fournier, M. Lapeyre-mestre, A. Sommet, J. Dupouy, J. Poutrain et al., Laboratory monitoring of patients treated with antihypertensive drugs and newly exposed to non steroidal anti-inflammatory drugs: a cohort study, PloS One, vol.7, issue.3, p.34187, 2012.

, Code de la santé publique-Article R5121-151. Code de la santé publique

M. Lapeyre-mestre, C. Sapède, N. Moore, P. Bilbault, P. Blin et al., Études pharmaco-épidémiologiques : quels niveaux de preuve et comment les atteindre ?, Thérapie, vol.68, issue.4, pp.241-247

A. Maladie and . Médicaments-biologie, Assurance Maladie sur le médicament : données générales, prescription, consommation, bon usage, Les études de l

. Exercer, Consultations sans prescription médicamenteuse : ressentis des médecins et des patients [Internet]. exercer, la revue francophone de Médecine Générale

. Afipa and A. Baromètre, , 2016.

. Disponible,

, ANSM : Agence nationale de sécurité du médicament et des produits de santé. Rapports/Synthèses-Médicaments-Analyse de vente des médicaments en France, 2013.

. Ministère-des-solidarités and . De-la-santé, Soins et maladies-Ministère des Solidarités et de la Santé

P. Noize, H. Bagheri, G. Durrieu, F. Haramburu, N. Moore et al., Life-threatening drug-associated hyperkalemia: a retrospective study from laboratory signals, Pharmacoepidemiol Drug Saf. juill, vol.20, issue.7, pp.747-53, 2011.

B. Bégaud, J. C. Evreux, J. Jouglard, and G. Lagier, Imputabilité des effets inattendus ou toxiques des médicaments. Actualisation de la méthode utilisée en France, Thérapie. avr, vol.40, issue.2, pp.111-119, 1985.

J. Montastruc, A. Sommet, H. Bagheri, and M. Lapeyre-mestre, Benefits and strengths of the disproportionality analysis for identification of adverse drug reactions in a pharmacovigilance database, Br J Clin Pharmacol. 1 déc, vol.72, issue.6, pp.905-913, 2011.

E. Agency, Screening for adverse reactions in EudraVigilance

E. Robert and F. Rosa, Valproate and birth defects. The Lancet, vol.322, p.1142, 1983.

B. H. Stricker and J. G. Tijssen, Serum sickness-like reactions to cefaclor, J Clin Epidemiol, vol.45, issue.10, pp.1177-84, 1992.

A. Sommet, S. Grolleau, H. Bagheri, M. Lapeyre-mestre, and J. L. Montastruc, French Network of Regional Pharmacovigilance Centres. Was the thrombotic risk of rofecoxib predictable from the French Pharmacovigilance Database before, Eur J Clin Pharmacol. août, vol.64, issue.8, pp.829-863, 2004.

C. Piccinni, D. Motola, G. Marchesini, and E. Poluzzi, Assessing the association of pioglitazone use and bladder cancer through drug adverse event reporting, Diabetes Care. juin, vol.34, issue.6, pp.1369-71, 2011.

Z. A. Marcum, M. E. Amuan, J. T. Hanlon, S. L. Aspinall, S. M. Handler et al., Prevalence of Unplanned Hospitalizations Caused by Adverse Drug Reactions Among Older Veterans, J Am Geriatr Soc. janv, vol.60, issue.1, pp.34-41, 2012.

D. J. Askenazi, D. I. Feig, N. M. Graham, S. Hui-stickle, and S. L. Goldstein, 3-5 year longitudinal follow-up of pediatric patients after acute renal failure, Kidney Int. 1 janv, vol.69, issue.1, pp.184-193, 2006.

B. Woolf, On Estimating the Relation Between Blood Group and Disease, Ann Hum Genet. 1 mai, vol.19, issue.4, pp.251-254, 1955.

C. Chao, H. Tsai, C. Wu, Y. Lin, N. Hsu et al., Cumulative Cardiovascular Polypharmacy Is Associated With the Risk of Acute Kidney Injury in Elderly Patients, Medicine

D. Hain and R. Paixao, The perfect storm: older adults and acute kidney injury, Crit Care Nurs Q. sept, vol.38, issue.3, pp.271-280, 2015.

T. G. Feest, A. Round, and S. Hamad, Incidence of severe acute renal failure in adults: results of a community based study, BMJ. 20 févr, vol.306, issue.6876, pp.481-484, 1993.

M. H. Rosner, Acute kidney injury in the elderly, Clin Geriatr Med. août, vol.29, issue.3, pp.565-78, 2013.

R. Camin, M. Cols, J. L. Chevarria, R. G. Osuna, M. Carreras et al., Acute kidney injury secondary to a combination of renin-angiotensin system inhibitors, diuretics and NSAIDS: « The Triple Whammy, Nefrol Publicacion Of Soc Espanola Nefrol, vol.35, issue.2, pp.197-206, 2015.

S. M. Handler, P. W. Cheung, C. M. Culley, S. Perera, K. Sl et al., Determining the incidence of drug-associated acute kidney injury in nursing home residents, J Am Med Dir Assoc. oct, vol.15, issue.10, pp.719-743, 2014.

R. J. Walker, R. R. Bailey, K. L. Lynn, and C. P. Swainson, Amoxycillin-induced acute interstitial nephritis, N Z Med J, vol.98, issue.788, p.866, 1985.

J. Soto, J. M. Bosch, A. Ortiz, M. J. Moreno, M. J. Gonzalez et al., Piperacillininduced acute interstitial nephritis, Nephron, vol.65, issue.1, pp.154-159, 1993.

S. J. Bakker, A. J. Luik, and K. M. Leunissen, Flucloxacillin-induced acute interstitial nephritis, Nephrol Dial Transplant Off Publ Eur Dial Transpl Assoc-Eur Ren Assoc, vol.10, issue.4, p.579, 1995.

A. O. Wai, A. M. Lo, A. Abdo, and F. Marra, Vancomycin-induced acute interstitial nephritis, Ann Pharmacother. nov, vol.32, issue.11, pp.1160-1164, 1998.

J. M. Lopez-novoa, Y. Quiros, L. Vicente, A. I. Morales, and F. J. Lopez-hernandez, New insights into the mechanism of aminoglycoside nephrotoxicity: an integrative point of view, Kidney Int. janv, vol.79, issue.1, pp.33-45, 2011.

G. Kahlmeter and J. I. Dahlager, Aminoglycoside toxicity-a review of clinical studies published between 1975 and 1982, J Antimicrob Chemother. 1 janv, vol.13, pp.9-22, 1984.

T. N. Fraser, A. A. Avellaneda, E. A. Graviss, and D. M. Musher, Acute kidney injury associated with trimethoprim/sulfamethoxazole, J Antimicrob Chemother. 5 janv, vol.67, issue.5, pp.1271-1278, 2012.

M. Bald, F. Ratjen, W. Nikolaizik, and A. M. Wingen, Ciprofloxacin-induced acute renal failure in a patient with cystic fibrosis, Pediatr Infect Dis J. mars, vol.20, issue.3, pp.320-321, 2001.

W. K. Lo, K. I. Rolston, E. B. Rubenstein, and G. P. Bodey, CIprofloxacin-induced nephrotoxicity in patients with cancer, Arch Intern Med. 24 mai, vol.153, issue.10, pp.1258-62, 1993.

S. Badal, Y. F. Her, L. J. Maher, and I. , Nonantibiotic Effects of Fluoroquinolones in Mammalian Cells, J Biol Chem. 4 sept, vol.290, issue.36, p.22287, 2015.

S. Chiba, K. Tsuchiya, H. Sakashita, E. Ito, and N. Inase, Rifampicin-induced acute kidney injury during the initial treatment for pulmonary tuberculosis: a case report and literature review, Intern Med Tokyo Jpn, vol.52, issue.21, pp.2457-60, 2013.

J. M. Mauri, J. Fort, J. Bartolome, J. Camps, L. Capdevila et al., Antirifampicin antibodies in acute rifampicin-associated renal failure, Nephron, vol.31, issue.2, pp.177-186, 1982.

A. Giustina, G. Romanelli, A. Cimino, and G. Brunori, Low-dose acyclovir and acute renal failure, Ann Intern Med. févr, vol.108, issue.2, p.312, 1988.

B. N. Becker, P. Fall, C. Hall, D. Milam, J. Leonard et al., Rapidly progressive acute renal failure due to acyclovir: case report and review of the literature, Am J Kidney Dis Off J Natl Kidney, vol.22, issue.4, pp.611-616, 1993.

D. M. Clive and J. S. Stoff, Renal syndromes associated with nonsteroidal antiinflammatory drugs, N Engl J Med. 1 mars, vol.310, issue.9, pp.563-72, 1984.

C. Huerta, J. Castellsague, C. Varas-lorenzo, G. Rodríguez, and L. A. , Nonsteroidal antiinflammatory drugs and risk of ARF in the general population, Am J Kidney Dis Off J Natl Kidney Found. mars, vol.45, issue.3, pp.531-540, 2005.

S. Harirforoosh and F. Jamali, Renal adverse effects of nonsteroidal anti-inflammatory drugs, Expert Opin Drug Saf, vol.8, issue.6, pp.669-81, 2009.

M. Kashimura, M. Kondo, T. Abe, M. Shinohara, and S. Baba,

, Gan No Rinsho Jpn J Cancer Clin, vol.34, pp.2015-2023, 1988.

M. Tanaka, H. Kanamori, S. Yamaji, A. Mishima, H. Fujita et al., Low-dose cytarabine-induced hepatic and renal dysfunction in a patient with myelodysplastic syndrome, Anticancer Drugs. mars, vol.10, issue.3, pp.289-91, 1999.

S. Latcha, E. A. Jaimes, S. Patil, I. G. Glezerman, S. Mehta et al., Long-Term Renal Outcomes after Cisplatin Treatment, Clin J Am Soc Nephrol CJASN. 12 avr, 2016.

K. D. Jhaveri, V. Sakhiya, and S. Fishbane, NEphrotoxicity of the braf inhibitors vemurafenib and dabrafenib, JAMA Oncol, vol.1, issue.8, pp.1133-1137, 2015.

D. Cattaneo, N. Perico, F. Gaspari, and G. Remuzzi, Nephrotoxic aspects of cyclosporine, Transplant Proc. mars, vol.36, issue.2, pp.234-239, 2004.

A. M. De-mattos, A. J. Olyaei, and W. M. Bennett, Nephrotoxicity of immunosuppressive drugs: long-term consequences and challenges for the future, Am J Kidney Dis Off J Natl Kidney Found. févr, vol.35, issue.2, pp.333-379, 2000.

P. Ruggenenti, N. Perico, L. Mosconi, F. Gaspari, A. Benigni et al., Calcium channel blockers protect transplant patients from cyclosporine-induced daily renal hypoperfusion, Kidney Int. 1 mars, vol.43, issue.3, pp.706-717, 1993.

J. S. Chen, L. S. Li, D. R. Cheng, S. M. Ji, Q. Q. Sun et al., Effect of CYP3A5 genotype on renal allograft recipients treated with tacrolimus, Transplant Proc. juin, vol.41, issue.5, pp.1557-61, 2009.

H. M. Cooke, D. Besse, and A. , Angiotensin converting enzyme inhibitor-induced renal dysfunction: recommendations for prevention, Int J Clin Pharmacol Ther. févr, vol.32, issue.2, pp.65-70, 1994.

B. Jackson, P. G. Matthews, B. P. Mcgrath, and C. I. Johnston, Angiotensin converting enzyme inhibition in renovascular hypertension: frequency of reversible renal failure, Lancet Lond Engl. 28 janv, vol.1, issue.8370, pp.225-231, 1984.

A. N. Lasaridis and P. A. Sarafidis, Diabetic nephropathy and antihypertensive treatment: what are the lessons from clinical trials?, Am J Hypertens. août, vol.16, issue.8, pp.689-97, 2003.

J. Liotier, L. Cassagnes, F. Moustafa, L. Boyer, and J. Schmidt, Injections de produits iodés : les complications, les préventions possibles, Médecine Thérapeutique. 1 mars, vol.14, issue.2, pp.67-76, 2008.

P. Stratta, C. Bozzola, and M. Quaglia, Pitfall in nephrology: contrast nephropathy has to be differentiated from renal damage due to atheroembolic disease, J Nephrol. juin, vol.25, issue.3, pp.282-291, 2012.

Z. Glück and F. C. Reubi, Acute changes in renal function induced by bisoprolol, a new cardioselective beta-blocking agent, Eur J Clin Pharmacol, vol.31, issue.1, pp.107-118, 1986.

A. A. Ejaz, P. M. Fitzpatrick, W. E. Haley, A. Wasiluk, A. J. Durkin et al., Amlodipine Besylate Induced Acute Interstitial Nephritis, Nephron. 28 juill, vol.85, issue.4, pp.354-360, 2000.

R. L. Attridge, W. D. Linn, L. Ryan, J. Koeller, and C. R. Frei, Evaluation of the incidence and risk factors for development of fenofibrate-associated nephrotoxicity, J Clin Lipidol. févr, vol.6, issue.1, pp.19-26, 2012.

R. L. Attridge, C. R. Frei, L. Ryan, J. Koeller, and W. D. Linn, Fenofibrate-associated nephrotoxicity: a review of current evidence, Am J Health-Syst Pharm AJHP Off J Am Soc Health-Syst Pharm. 15 juill, vol.70, issue.14, pp.1219-1244, 2013.

S. A. Chapman, K. L. Gilkerson, T. D. Davin, and M. R. Pritzker, Acute renal failure and intravenous immune globulin: occurs with sucrose-stabilized, but not with D-sorbitolstabilized, formulation, Ann Pharmacother. déc, vol.38, issue.12, pp.2059-67, 2004.

J. A. Haskin, D. J. Warner, and D. U. Blank, Acute renal failure after large doses of intravenous immune globulin, Ann Pharmacother. août, vol.33, issue.7-8, pp.800-803, 1999.

L. N. Faught, M. Greff, M. J. Rieder, and G. Koren, Drug-induced acute kidney injury in children, Br J Clin Pharmacol, vol.80, issue.4, pp.901-910, 2015.

L. Oni, D. B. Hawcutt, M. A. Turner, M. W. Beresford, S. Mcwilliam et al., Optimising the use of medicines to reduce acute kidney injury in children and babies, Pharmacol Ther. juin, vol.174, pp.55-62, 2017.

, Point d'actualité sur le Levothyrox et les autres médicaments à base de lévothyroxineCommuniqué-ANSM : Agence nationale de sécurité du médicament et des produits de santé, ANSM : Agence nationale de sécurité du médicament et des produits de santé

M. Pierson-marchandise, V. Gras, J. Moragny, J. Micallef, L. Gaboriau et al., The drugs that mostly frequently induce acute kidney injury: a case ? noncase study of a pharmacovigilance database, Br J Clin Pharmacol. 1 juin, vol.83, issue.6, pp.1341-1350, 2017.